UK markets open in 1 hour 50 minutes

Enliven Therapeutics, Inc. (ELVN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
21.47-0.37 (-1.69%)
At close: 04:00PM EDT
21.02 -0.45 (-2.10%)
After hours: 07:36PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6666
Avg. Estimate-0.55-0.6-2.26-2.77
Low estimate-0.65-0.69-2.49-3.4
High estimate-0.49-0.52-2.02-2.32
Year ago EPS-0.41-0.51-2.01-2.26
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3344
Avg. EstimateN/AN/AN/A10k
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/A50k
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.36-0.47-0.54-0.57
Actual EPS-0.41-0.51-0.47-0.54
Difference-0.05-0.040.070.03
Surprise %-13.90%-8.50%13.00%5.30%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.55-0.6-2.26-2.77
7 days ago-0.56-0.62-2.31-2.86
30 days ago-0.57-0.62-2.3-2.82
60 days ago-0.62-0.67-2.36-2.96
90 days ago-0.63-0.69-2.42-3.02
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesELVNIndustrySector(s)S&P 500
Current qtr.-34.10%N/AN/AN/A
Next qtr.-17.60%N/AN/AN/A
Current year-12.40%N/AN/AN/A
Next year-22.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A